Suppr超能文献

前庭神经鞘瘤的治疗。第一部分。显微手术失败与延迟立体定向放射外科的作用。

Vestibular schwannoma management. Part I. Failed microsurgery and the role of delayed stereotactic radiosurgery.

作者信息

Pollock B E, Lunsford L D, Flickinger J C, Clyde B L, Kondziolka D

机构信息

Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

J Neurosurg. 1998 Dec;89(6):944-8. doi: 10.3171/jns.1998.89.6.0944.

Abstract

OBJECT

The purpose of this study was to analyze patient outcomes and to define the role of radiosurgery in patients who have undergone prior microsurgical resection of their vestibular schwannoma.

METHODS

The authors evaluated the pre- and postoperative clinical and neuroimaging characteristics of 76 consecutive patients with 78 vestibular schwannomas who underwent radiosurgery after previous surgical resection. Twenty-nine patients (37% of tumors) had undergone more than one prior resection. Forty-three patients (55% of tumors) had significant impairment of facial nerve function (House-Brackmann Grades III-VI) after their microsurgical procedure; 50% had trigeminal sensory loss, and 96% had poor speech discrimination (< 50%). The median evaluation period following radiosurgery was 43 months (range 12-101 months). Tumor growth control after radiosurgery was achieved in 73 tumors (94%). Six patients underwent additional surgical resection despite radiosurgery (median of 32 months after radiosurgery), and one patient underwent repeated radiosurgery for tumor progression outside the irradiated volume. Eleven (23%) of 47 patients with Grades I to III facial function before radiosurgery developed increased facial weakness after radiosurgery. Eleven patients (14%) developed new trigeminal symptoms.

CONCLUSIONS

Radiosurgery proved to be a safe and effective alternative to additional microsurgery in patients in whom the initial microsurgical removal failed. Stereotactic radiosurgery should be considered for all patients who have regrowth or progression of previously surgically treated vestibular schwannomas.

摘要

目的

本研究旨在分析患者的预后情况,并明确放射外科手术在前庭神经鞘瘤患者先前接受显微手术切除后的作用。

方法

作者评估了76例连续患者的78例前庭神经鞘瘤,这些患者在先前手术切除后接受了放射外科手术,分析其术前和术后的临床及神经影像学特征。29例患者(占肿瘤的37%)先前接受了不止一次切除手术。43例患者(占肿瘤的55%)在显微手术后出现面神经功能严重受损(House-Brackmann分级III-VI级);50%有三叉神经感觉丧失,96%有言语辨别能力差(<50%)。放射外科手术后的中位评估期为43个月(范围12-101个月)。73个肿瘤(94%)在放射外科手术后实现了肿瘤生长控制。6例患者尽管接受了放射外科手术仍接受了额外的手术切除(放射外科手术后中位时间为32个月),1例患者因照射体积外的肿瘤进展接受了重复放射外科手术。放射外科手术前面神经功能为I至III级的47例患者中有11例(23%)在放射外科手术后出现面神经无力加重。11例患者(14%)出现了新的三叉神经症状。

结论

对于初次显微手术切除失败的患者,放射外科手术被证明是一种安全有效的替代额外显微手术的方法。对于先前接受手术治疗的前庭神经鞘瘤出现复发或进展的所有患者,均应考虑立体定向放射外科手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验